Drug ID: | NPD1402 |
Drug Name: | |
Molecular Formula: | C14H21N3O |
Canonical SMILES: | C[C@H](C1CCC(CC1)C(=O)N=c1cc[nH]cc1)N |
Standard InCHI: | InChI=1S/C14H21N3O/c1-10(15)11-2-4-12(5-3-11)14(18)17-13-6-8-16-9-7-13/h6-12H,2-5,15H2,1H3,(H,16,17,18)/t10-,11?,12?/m1/s1 |
Standard InCHIKey: | IYOZTVGMEWJPKR-VOMCLLRMSA-N |
Max Developmental Stage: | Approved |
Max Developmental Stage Source: | TTD |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
Tanimoto coefficient is calculated based on PubChem 881-bit substructure fingerprints.
High Similarity Level: Tc>=0.85; Intermediate Similarity Level: 0.7 <= Tc < 0.85; Remote Similarity Level: 0.65 <= Tc < 0.7
TTD | DNC001520; DAP001537 |
DrugBank | |
ChEMBL | |
IUPHAR/BPS | |
PharmaGKB | |
KEGG Drug | |
PubChem CID | 448042 |
ChEBI | |
CAS Number |
Molecular Weight | 247.17 |
ALogP | -1.7929 |
MLogP | 2.56 |
XLogP | 1.589 |
HDA | 4 |
HBD | 2 |
Rotatable Bonds | 5 |
TPSA | 67.48 |
RO5 Violation | 0 |